Needles Market
By Type;
Conventional Needles and Safety NeedlesBy Delivery Site;
Intradermal, Subcutaneous, Intravenous, ntramuscular and IntraperitonealBy Product;
Suture, Blood Collection and InsufflationBy Application;
Pen Needles In Diabetes, Blood Collection Needles, Surgical Sutures Needles, Ophthalmic Procedure Needles, Dentistry Needle, Insufflation Needle and OthersBy Geography;
North America, Europe, Asia Pacific, Middle East & Africa and Latin America - Report Timeline (2021 - 2031)Needles Market Overview
Needles Market (USD Million)
Needles Market was valued at USD 7,130.57 million in the year 2024. The size of this market is expected to increase to USD 10,792.74 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 6.1%.
Needles Market
*Market size in USD million
CAGR 6.1 %
Study Period | 2025 - 2031 |
---|---|
Base Year | 2024 |
CAGR (%) | 6.1 % |
Market Size (2024) | USD 7,130.57 Million |
Market Size (2031) | USD 10,792.74 Million |
Market Concentration | Medium |
Report Pages | 389 |
Major Players
- Medtronic (Ireland)
- Ethicon US, LLC. (U.S.)
- Thermo Fisher Scientific Inc. (U.S.)
- Novo Nordisk A/S (Denmark), BD (U.S.)
- Stryker (U.S.)
- Boston Scientific Corporation (U.S.)
- Luminex Corporation ((U.S.)
- Illumina, Inc (U.S.)
- Bio-Rad Laboratories, Inc. (U.S.)
- QIAGEN (Netherlands)
- Abcam plc (U.K.)
- Merck KGaA (Germany)
- Promega Corporation (U.S.)
- Siemens (Germany)
- PerkinElmer, Inc. (U.S.)
- Shimadzu Corporation (Japan)
Market Concentration
Consolidated - Market dominated by 1 - 5 major players
Needles Market
Fragmented - Highly competitive market without dominant players
The Needles Market is witnessing considerable growth driven by increasing demand in medical procedures and diagnostic applications. With over 65% usage rate in therapeutic injections, the market is evolving to accommodate advanced technologies and safety innovations. Rising concerns over cross-contamination and needlestick injuries are prompting the development of safety-engineered needles, boosting adoption across clinical settings. The market also reflects an increasing shift toward single-use sterile needles, enhancing procedural efficiency and hygiene.
Strategic Collaborations and Mergers
Mergers and collaborative partnerships account for over 52% of business development strategies in the Needles Market. Companies are actively investing in joint ventures to strengthen R&D and broaden their technological capabilities. These partnerships often focus on developing eco-friendly materials, enhancing both product lifecycle and sustainability. Mergers are also being used as a route to accelerate market penetration in high-demand sectors such as outpatient care and chronic disease management.
Opportunities and Growth Initiatives
There are rising opportunities in personalized medicine, contributing to a 61% increase in customized needle-based therapies. Initiatives to improve home-based care solutions and minimally invasive procedures are further propelling the market. Additionally, companies are introducing multi-functional needles designed to integrate diagnostics and treatment, offering a compelling opportunity for market expansion. These developments align with the broader trend of improving patient-centric care through precision devices.
Future Outlook and Innovation Trends
The future outlook for the Needles Market remains promising, driven by technological integration and innovation-focused strategies. Approximately 60% of market leaders are prioritizing investments in AI-assisted needle guidance systems and robotic-controlled injections. As demand for accuracy, efficiency, and safety grows, the market is expected to see strong momentum in automation and smart needle systems. Continued focus on product innovation and expansion strategies will play a crucial role in shaping the market's long-term trajectory.
Needles Market Recent Developments
- In June 2022, Wuxi Biologics, global contract research, development, and manufacturing organization (CRDMO), launched the Good Manufacturing Practice (GMP) operation of its new drug product facility DP5 located in Wuxi, China. The facility offers multiple volume delivery options for pre-filled syringes (PFS).
- In February 2022, Owen Mumford Pharmaceutical Services launched the UniSafe 1mL safety device for pre-filled syringes has been approved as a combination product in Asia.
Needles Market Segment Analysis
In this report, the Needles Market has been segmented by Delivery Site, Product, Application, and Geography.
Needles Market, Segmentation by Delivery Site
The Needles Market has been segmented by Delivery Site into Intradermal, Subcutaneous, Intravenous, Intramuscular, and Intraperitoneal.
Intradermal
Intradermal needle delivery is gaining traction in vaccine administration and diagnostic testing due to its shallow penetration and enhanced antigen response. The segment benefits from rising immunization programs and biopharmaceutical advancements. Precision dosing and lower reactogenicity are key drivers. Innovations in microneedle technology are further expanding the clinical utility of intradermal injection techniques.
Subcutaneous
Subcutaneous needle delivery remains essential for chronic disease management, particularly in insulin and hormone therapy. The segment is propelled by the increasing prevalence of diabetes and self-administration trends. Enhanced comfort, smaller gauges, and user-friendly pen systems are improving patient compliance. Demand is also supported by home healthcare and biologics delivery applications.
Intravenous
Intravenous needle use dominates hospital and emergency care settings, facilitating rapid drug and fluid administration. High adoption is driven by critical care, oncology, and anesthetic procedures. Product innovations such as safety IV catheters and closed-system devices are minimizing needle-stick injuries. Increasing surgical volumes and advanced treatment regimens support steady growth.
Intramuscular
Intramuscular needles are frequently used for vaccine delivery and long-acting injectable medications. The segment gains from public vaccination drives, especially for influenza, tetanus, and COVID-19. Their ability to deliver drugs deep into tissue ensures rapid absorption and efficacy. Ongoing developments in needle geometry and formulation compatibility continue to enhance the segment.
Intraperitoneal
Intraperitoneal delivery plays a critical role in chemotherapy and dialysis. This segment is niche but highly relevant in treating peritoneal carcinomatosis and renal disorders. Precision and controlled drug dispersion make intraperitoneal access advantageous in select clinical scenarios. Research advancements are expected to increase its therapeutic applications.
Needles Market, Segmentation by Product
The Needles Market has been segmented by Product into Suture, Blood Collection, and Insufflation.
Suture
Suture needles are a core component in surgical procedures and wound closure, commanding significant market share. Rising surgical volumes and trauma cases globally are driving consistent demand. Enhanced materials and ergonomic designs are improving surgeon efficiency and reducing tissue trauma. Biocompatible and absorbable options are gaining traction in minimally invasive surgery.
Blood Collection
Blood collection needles are widely used in clinical diagnostics and transfusions, making them indispensable in healthcare. This segment is growing due to increased diagnostic testing volumes, preventive health screenings, and infectious disease surveillance. Safety-engineered needles are improving clinician safety and meeting regulatory mandates. Innovations in vacutainer systems enhance sample integrity.
Insufflation
Insufflation needles are vital in laparoscopic surgeries for creating pneumoperitoneum. As minimally invasive procedures rise globally, this segment experiences robust demand. Enhanced precision, pressure control, and reduced insertion trauma are central to product advancements. Growth is supported by the adoption of laparoscopy in both developed and emerging healthcare systems.
Needles Market, Segmentation by Application
The Needles Market has been segmented by Application into Pen Needles in Diabetes, Blood Collection Needles, Surgical Sutures Needles, Ophthalmic Procedure Needles, Dentistry Needle, Insufflation Needle, and Others.
Pen Needles in Diabetes
Pen needles are critical for insulin administration in diabetes care and are designed for daily, self-administered injections. The segment benefits from growing diabetic populations and technological improvements in pen devices. User-friendly, short, and fine-gauge designs enhance comfort and adherence. Increased availability through retail pharmacies also fuels uptake globally.
Blood Collection Needles
Blood collection needles support diagnostics, disease screening, and clinical trials. Their market is propelled by expanded testing programs and personalized medicine. Pre-attached safety devices and multiple gauge variants improve usability and safety. The growing role of automation and laboratory digitization contributes to demand for compatible needle solutions.
Surgical Sutures Needles
Surgical suture needles are indispensable in hospitals for internal and external wound closure. This application thrives with the rise in elective and trauma surgeries. Stainless steel variants with curved profiles are standard in diverse surgical settings. Increasing preference for barbed and absorbable suture systems is also shaping demand trends.
Ophthalmic Procedure Needles
These needles are specialized for delicate eye procedures such as cataract and retinal surgeries. The segment is expanding with the rising prevalence of age-related ocular diseases. Micron-scale precision, ultra-sharp tips, and fine bevel designs are key differentiators. Product customization and partnerships with ophthalmic centers are boosting adoption.
Dentistry Needle
Dentistry needles are used for local anesthetic delivery in dental procedures. The market is witnessing growth due to increased dental tourism and aesthetic dentistry. Single-use, disposable designs enhance infection control. Shorter, beveled needles reduce discomfort and are preferred for pediatric and geriatric dentistry.
Insufflation Needle
Insufflation needles are integral to laparoscopic entry and CO₂ gas administration. This application area aligns with the surge in minimally invasive surgeries. Products with built-in safety shields and depth indicators are highly favored. Strong hospital infrastructure and rising surgical volumes ensure continued segment expansion.
Others
This segment includes needles used in biopsy, spinal, and aesthetic procedures. Growing medical aesthetics, chronic pain interventions, and cancer diagnostics contribute to demand. Specialty needle types like cannulas and micro-needles are gaining popularity. Advancements in needle coatings and imaging guidance improve procedural outcomes.
Needles Market, Segmentation by Geography
In this report, the Needles Market has been segmented by Geography into North America, Europe, Asia Pacific, Middle East & Africa, and Latin America.
Regions and Countries Analyzed in this Report
Needles Market Share (%), by Geographical Region
North America
North America holds the largest share at 40.5%, attributed to advanced healthcare systems and a high volume of surgical procedures. The region’s strong focus on preventive diagnostics and chronic disease management drives needle demand. Regulatory support for safety devices and the presence of leading manufacturers bolster market leadership.
Europe
Europe accounts for 26.7% of the market and is characterized by widespread healthcare access and a growing geriatric population. Needle usage in ambulatory care and vaccination programs continues to expand. Supportive reimbursement structures and rising minimally invasive surgeries promote consistent growth.
Asia Pacific
Asia Pacific contributes 21.3% and is one of the fastest-growing markets due to rising healthcare investments and large patient volumes. Countries like China and India are leading in diabetes care and diagnostics. Increasing awareness, affordability, and government-backed immunization programs drive uptake.
Middle East & Africa
Middle East & Africa represents 6.1%, supported by improving access to basic and advanced medical care. Urbanization, medical tourism, and government initiatives for infectious disease management are stimulating growth. Investments in public health infrastructure also enhance needle distribution channels.
Latin America
Latin America holds 5.4% of the market, led by Brazil and Mexico. Rising healthcare awareness and increasing surgical and dental procedures support demand. Expanding private hospital networks and enhanced diagnostic capabilities further strengthen the region’s growth outlook.
Market Trends
This report provides an in depth analysis of various factors that impact the dynamics of Global Needles Market. These factors include; Market Drivers, Restraints, and Opportunities.
Drivers:
- Rising chronic disease prevalence
- Demand for minimally invasive procedures
- Growing geriatric population
- Patient safety importance
-
Point-of-care diagnostics adoption - Point-of-care diagnostics adoption serves as a significant driver propelling the growth and innovation within the Global Needles Market. This adoption is driven by the increasing demand for rapid and accurate diagnostic testing at the point of care, where healthcare providers can promptly diagnose medical conditions and initiate appropriate treatment interventions. Point-of-care diagnostics encompass a wide range of tests and assays that can be performed near the patient, such as in clinics, physician offices, emergency departments, and community settings, without the need for specialized laboratory equipment or extensive sample processing.
The adoption of point-of-care diagnostics is fueled by several factors, including the growing prevalence of chronic diseases, infectious diseases, and lifestyle-related conditions that require timely diagnosis and management. By enabling rapid testing and immediate result reporting, point-of-care diagnostics empower healthcare providers to make informed clinical decisions, optimize patient care pathways, and improve treatment outcomes. This is particularly crucial in settings where timely diagnosis and intervention can significantly impact patient morbidity and mortality, such as in critical care, emergency medicine, and remote healthcare settings.
Advancements in technology have led to the development of portable, handheld, and easy-to-use diagnostic devices that enable rapid and accurate testing at the point of care. These devices often utilize disposable cartridges or test strips that contain reagents for analyzing biological samples, such as blood, urine, or saliva, allowing for on-the-spot testing without the need for centralized laboratory facilities. The adoption of point-of-care diagnostics is further facilitated by the increasing availability and affordability of these innovative diagnostic tools, making them accessible to healthcare providers in diverse clinical settings worldwide.
Restraints:
- Regulatory hurdles
- Limited healthcare access
- Needlestick injury concerns
- Sterilization and waste issues
-
Skilled professional shortages - Skilled professional shortages pose a significant restraint on the Global Needles Market, impacting various facets of healthcare delivery, including needle utilization, patient care, and procedural efficiency. This restraint is characterized by a shortage of trained and qualified healthcare professionals, including physicians, nurses, phlebotomists, and medical laboratory technicians, who are proficient in performing needle-based medical procedures, such as venipuncture, injections, and specimen collection.
The shortage of skilled professionals can hinder the effective utilization of needles and needle-based medical devices, as healthcare facilities may face challenges in adequately staffing clinical teams responsible for performing medical procedures requiring needle insertion or manipulation. This shortage can lead to increased workloads, time constraints, and procedural delays, resulting in decreased efficiency, longer wait times for patients, and reduced quality of care.
The shortage of skilled professionals may impact patient safety and procedural outcomes, as inexperienced or inadequately trained healthcare providers may be more prone to errors, complications, and adverse events during needle-based procedures. Improper needle insertion techniques, inadequate sample collection practices, and incorrect medication administration procedures can increase the risk of patient discomfort, injury, and procedural complications, undermining the overall quality and safety of healthcare delivery.
Opportunities:
- Safety needle tech development
- Real-time smart needle adoption
- Needle-free drug delivery
- Tailored needle solutions
-
Telemedicine needle integration - Telemedicine needle integration presents a promising opportunity within the Global Needles Market, offering innovative solutions to enhance healthcare delivery, improve patient access to medical services, and streamline needle-based procedures in remote and virtual care settings. This opportunity arises from the increasing adoption of telemedicine platforms and technologies, which enable healthcare providers to deliver medical services, consultations, and interventions remotely, leveraging telecommunications and digital health tools.
Integration of needles into telemedicine platforms allows healthcare providers to perform needle-based medical procedures, such as injections, venipuncture, and specimen collection, during virtual consultations and remote patient encounters. This integration enables patients to receive essential medical services and treatments without the need for in-person visits to healthcare facilities, overcoming barriers related to geographic distance, mobility limitations, and access to specialized healthcare services.
Telemedicine needle integration facilitates real-time guidance and supervision of needle-based procedures by healthcare providers, who can remotely observe and instruct patients or caregivers on proper needle insertion techniques, sample collection methods, and medication administration procedures. Through live video consultations, healthcare providers can assess patient conditions, provide personalized guidance, and address any concerns or questions related to needle-based procedures, ensuring safe and effective performance in home or community settings.
Competitive Landscape Analysis
Key players in Global Needles Market include,
- Medtronic (Ireland)
- Ethicon US, LLC. (U.S.)
- Thermo Fisher Scientific Inc. (U.S.)
- Novo Nordisk A/S (Denmark), BD (U.S.)
- Stryker (U.S.)
- Boston Scientific Corporation (U.S.)
- Luminex Corporation ((U.S.)
- Illumina, Inc (U.S.)
- Bio-Rad Laboratories, Inc. (U.S.)
- QIAGEN (Netherlands)
- Abcam plc (U.K.)
- Merck KGaA (Germany)
- Promega Corporation (U.S.)
- Siemens (Germany)
- PerkinElmer, Inc. (U.S.)
- Shimadzu Corporation (Japan)
In this report, the profile of each market player provides following information:
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Introduction
- Research Objectives and Assumptions
- Research Methodology
- Abbreviations
- Market Definition & Study Scope
- Executive Summary
- Market Snapshot, By Type
- Market Snapshot, By Delivery Site
- Market Snapshot, By Product
- Market Snapshot, By Application
- Market Snapshot, By Region
- Needles Market Dynamics
- Drivers, Restraints and Opportunities
- Drivers
- Rising chronic disease prevalence
- Demand for minimally invasive procedures
- Growing geriatric population
- Patient safety importance
- Point-of-care diagnostics adoption
- Restraints
- Regulatory hurdles
- Limited healthcare access
- Needlestick injury concerns
- Sterilization and waste issues
- Skilled professional shortages
- Opportunities
- Safety needle tech development
- Real-time smart needle adoption
- Needle-free drug delivery
- Tailored needle solutions
- Telemedicine needle integration
- Drivers
- PEST Analysis
- Political Analysis
- Economic Analysis
- Social Analysis
- Technological Analysis
- Porter's Analysis
- Bargaining Power of Suppliers
- Bargaining Power of Buyers
- Threat of Substitutes
- Threat of New Entrants
- Competitive Rivalry
- Drivers, Restraints and Opportunities
- Market Segmentation
-
Needles Market, By Type, 2021 - 2031 (USD Million)
-
Conventional Needles
-
Safety Needles
-
- Needles Market, By Delivery Site, 2021 - 2031 (USD Million)
- Intradermal
- Subcutaneous
- Intravenous
- ntramuscular
- Intraperitoneal
- Needles Market, By Product 2021 - 2031 (USD Million)
- Suture
- Blood Collection
- Insufflation
- Needles Market, By Application, 2021 - 2031 (USD Million)
- Pen Needles In Diabetes
- Blood Collection Needles
- Surgical Sutures Needles
- Ophthalmic Procedure Needles
- Dentistry Needle
- Insufflation Needle
- Others
- Needles Market, By Geography, 2021 - 2031 (USD Million)
- North America
- United States
- Canada
- Europe
- Germany
- United Kingdom
- France
- Italy
- Spain
- Nordic
- Benelux
- Rest of Europe
- Asia Pacific
- Japan
- China
- India
- Australia & New Zealand
- South Korea
- ASEAN (Association of South East Asian Countries)
- Rest of Asia Pacific
- Middle East & Africa
- GCC
- Israel
- South Africa
- Rest of Middle East & Africa
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- North America
-
- Competitive Landscape
- Company Profiles
- Medtronic (Ireland)
- Ethicon US, LLC. (U.S.)
- Thermo Fisher Scientific Inc. (U.S.)
- Novo Nordisk A/S (Denmark), BD (U.S.)
- Stryker (U.S.)
- Boston Scientific Corporation (U.S.)
- Luminex Corporation ((U.S.)
- Illumina, Inc (U.S.)
- Bio-Rad Laboratories, Inc. (U.S.)
- QIAGEN (Netherlands)
- Abcam plc (U.K.)
- Merck KGaA (Germany)
- Promega Corporation (U.S.)
- Siemens (Germany)
- PerkinElmer, Inc. (U.S.)
- Shimadzu Corporation (Japan)
- Company Profiles
- Analyst Views
- Future Outlook of the Market